SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-058739
Filing Date
2018-11-09
Accepted
2018-11-09 16:06:56
Documents
49
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tv506017_10q.htm 10-Q 404344
2 EXHIBIT 31.1 tv506017_ex31-1.htm EX-31.1 10269
3 EXHIBIT 31.2 tv506017_ex31-2.htm EX-31.2 11183
4 EXHIBIT 32.1 tv506017_ex32-1.htm EX-32.1 4662
5 EXHIBIT 32.2 tv506017_ex32-2.htm EX-32.2 4544
  Complete submission text file 0001144204-18-058739.txt   4594497

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT abeo-20180930.xml EX-101.INS 1545858
7 XBRL TAXONOMY EXTENSION SCHEMA abeo-20180930.xsd EX-101.SCH 22674
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abeo-20180930_cal.xml EX-101.CAL 25609
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abeo-20180930_def.xml EX-101.DEF 181745
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE abeo-20180930_lab.xml EX-101.LAB 186216
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abeo-20180930_pre.xml EX-101.PRE 201977
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 181173135
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1